APA (7th ed.) Citation

Moon, H., Matarese, G., Brennan, A. M., Chamberland, J. P., Liu, X., Fiorenza, C. G., . . . Mantzoros, C. S. (2011). Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance. Diabetes (New York, N.Y.), 60(6), 1647-1656. https://doi.org/10.2337/db10-1791

Chicago Style (17th ed.) Citation

Moon, Hyun-Seuk, et al. "Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance." Diabetes (New York, N.Y.) 60, no. 6 (2011): 1647-1656. https://doi.org/10.2337/db10-1791.

MLA (9th ed.) Citation

Moon, Hyun-Seuk, et al. "Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance." Diabetes (New York, N.Y.), vol. 60, no. 6, 2011, pp. 1647-1656, https://doi.org/10.2337/db10-1791.